JP2003522145A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003522145A5 JP2003522145A5 JP2001557560A JP2001557560A JP2003522145A5 JP 2003522145 A5 JP2003522145 A5 JP 2003522145A5 JP 2001557560 A JP2001557560 A JP 2001557560A JP 2001557560 A JP2001557560 A JP 2001557560A JP 2003522145 A5 JP2003522145 A5 JP 2003522145A5
- Authority
- JP
- Japan
- Prior art keywords
- nicotine
- methylpyrazole
- piperidino
- dichlorophenyl
- carboxamide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 8
- 229960002715 nicotine Drugs 0.000 description 8
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 8
- JZCPYUJPEARBJL-UHFFFAOYSA-N rimonabant Chemical compound CC=1C(C(=O)NN2CCCCC2)=NN(C=2C(=CC(Cl)=CC=2)Cl)C=1C1=CC=C(Cl)C=C1 JZCPYUJPEARBJL-UHFFFAOYSA-N 0.000 description 8
- 150000003839 salts Chemical class 0.000 description 8
- 239000012453 solvate Substances 0.000 description 7
- 241000208125 Nicotiana Species 0.000 description 4
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 4
- 239000008194 pharmaceutical composition Substances 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 3
- 229940123685 Monoamine oxidase inhibitor Drugs 0.000 description 2
- 206010057852 Nicotine dependence Diseases 0.000 description 2
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 2
- 208000025569 Tobacco Use disease Diseases 0.000 description 2
- 239000000556 agonist Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000002899 monoamine oxidase inhibitor Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR00/01682 | 2000-02-09 | ||
| FR0001682A FR2804604B1 (fr) | 2000-02-09 | 2000-02-09 | Utilisation d'un antagoniste des recepteurs aux cannabinoides centraux pour la preparation de medicaments utiles pour faciliter l'arret de la consommation de tabac |
| PCT/FR2001/000356 WO2001058450A2 (fr) | 2000-02-09 | 2001-02-07 | Utilisation d'un antagoniste des recepteurs aux cannabinoides centraux pour la preparation de medicaments utiles pour faciliter l'arret de la consommation de tabac |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009217269A Division JP2010018622A (ja) | 2000-02-09 | 2009-09-18 | セントラルカンナビノイドレセプター拮抗剤のタバコ消費を止める助けに有用である医薬品への使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003522145A JP2003522145A (ja) | 2003-07-22 |
| JP2003522145A5 true JP2003522145A5 (enExample) | 2006-01-05 |
Family
ID=8846875
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001557560A Ceased JP2003522145A (ja) | 2000-02-09 | 2001-02-07 | セントラルカンナビノイドレセプター拮抗剤のタバコ消費を止める助けに有用である医薬品への使用 |
| JP2009217269A Withdrawn JP2010018622A (ja) | 2000-02-09 | 2009-09-18 | セントラルカンナビノイドレセプター拮抗剤のタバコ消費を止める助けに有用である医薬品への使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009217269A Withdrawn JP2010018622A (ja) | 2000-02-09 | 2009-09-18 | セントラルカンナビノイドレセプター拮抗剤のタバコ消費を止める助けに有用である医薬品への使用 |
Country Status (32)
| Country | Link |
|---|---|
| US (2) | US6930122B2 (enExample) |
| EP (1) | EP1257275B1 (enExample) |
| JP (2) | JP2003522145A (enExample) |
| CN (1) | CN1250220C (enExample) |
| AR (1) | AR028505A1 (enExample) |
| AT (1) | ATE292467T1 (enExample) |
| AU (1) | AU781827B2 (enExample) |
| BG (2) | BG110386A (enExample) |
| BR (1) | BR0108126A (enExample) |
| CA (1) | CA2397262C (enExample) |
| CZ (1) | CZ296685B6 (enExample) |
| DE (1) | DE60109903T2 (enExample) |
| DK (1) | DK1257275T3 (enExample) |
| EE (1) | EE04836B1 (enExample) |
| ES (1) | ES2240416T3 (enExample) |
| FR (1) | FR2804604B1 (enExample) |
| HU (1) | HU225328B1 (enExample) |
| IL (1) | IL150710A0 (enExample) |
| IS (1) | IS6450A (enExample) |
| MX (1) | MXPA02007766A (enExample) |
| NO (1) | NO324521B1 (enExample) |
| NZ (1) | NZ519924A (enExample) |
| PL (1) | PL201685B1 (enExample) |
| PT (1) | PT1257275E (enExample) |
| RS (1) | RS50404B (enExample) |
| RU (1) | RU2257207C2 (enExample) |
| SI (1) | SI1257275T1 (enExample) |
| SK (1) | SK284952B6 (enExample) |
| TW (1) | TWI243677B (enExample) |
| UA (1) | UA72783C2 (enExample) |
| WO (1) | WO2001058450A2 (enExample) |
| ZA (1) | ZA200205317B (enExample) |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2804604B1 (fr) * | 2000-02-09 | 2005-05-27 | Sanofi Synthelabo | Utilisation d'un antagoniste des recepteurs aux cannabinoides centraux pour la preparation de medicaments utiles pour faciliter l'arret de la consommation de tabac |
| US6462237B1 (en) * | 2001-06-14 | 2002-10-08 | Usv Limited | Cyclodextrin stabilized pharmaceutical compositions of bupropion hydrochloride |
| CN1568432A (zh) | 2001-08-13 | 2005-01-19 | 霍尼韦尔国际公司 | 使用沟槽为晶片承载的半导体器件提供电流控制 |
| NZ535349A (en) | 2002-03-08 | 2007-01-26 | Signal Pharm Inc | JNK inhibitors with chemotherapeutic agents in a combination therapy for treating or preventing cancer and other proliferative disorders in refractory patients in particular |
| ATE486842T1 (de) | 2002-03-12 | 2010-11-15 | Merck Sharp & Dohme | Substituierte amide |
| AU2003215024B2 (en) | 2002-03-26 | 2008-02-21 | Merck Sharp & Dohme Corp. | Spirocyclic amides as cannabinoid receptor modulators |
| EP1492784A4 (en) | 2002-03-28 | 2006-03-29 | Merck & Co Inc | SUBSTITUTED 2,3-DIPHENYLPYRIDINES |
| EP1499306A4 (en) | 2002-04-12 | 2007-03-28 | Merck & Co Inc | BICYCLIC AMIDE |
| US6825209B2 (en) | 2002-04-15 | 2004-11-30 | Research Triangle Institute | Compounds having unique CB1 receptor binding selectivity and methods for their production and use |
| ATE375349T1 (de) | 2002-08-02 | 2007-10-15 | Merck & Co Inc | Substituierte furo(2,3-b)pyridin derivate |
| AU2003275242B2 (en) | 2002-09-27 | 2010-03-04 | Merck Sharp & Dohme Corp. | Substituted pyrimidines |
| US7129239B2 (en) | 2002-10-28 | 2006-10-31 | Pfizer Inc. | Purine compounds and uses thereof |
| US7247628B2 (en) | 2002-12-12 | 2007-07-24 | Pfizer, Inc. | Cannabinoid receptor ligands and uses thereof |
| WO2004058145A2 (en) | 2002-12-19 | 2004-07-15 | Merck & Co., Inc. | Substituted amides |
| US7329658B2 (en) | 2003-02-06 | 2008-02-12 | Pfizer Inc | Cannabinoid receptor ligands and uses thereof |
| US7176210B2 (en) | 2003-02-10 | 2007-02-13 | Pfizer Inc. | Cannabinoid receptor ligands and uses thereof |
| US7145012B2 (en) | 2003-04-23 | 2006-12-05 | Pfizer Inc. | Cannabinoid receptor ligands and uses thereof |
| US7268133B2 (en) | 2003-04-23 | 2007-09-11 | Pfizer, Inc. Patent Department | Cannabinoid receptor ligands and uses thereof |
| US20040224963A1 (en) * | 2003-05-09 | 2004-11-11 | Pfizer Inc | Pharmaceutical composition for the prevention and treatment of nicotine addiction in a mammal |
| US20040224962A1 (en) * | 2003-05-09 | 2004-11-11 | Pfizer Inc | Pharmaceutical composition for the treatment of obesity or to facilitate or promote weight loss |
| US7169942B2 (en) * | 2003-05-20 | 2007-01-30 | University Of Tennessee Research Foundation | Cannabinoid derivatives, methods of making, and use thereof |
| US7232823B2 (en) | 2003-06-09 | 2007-06-19 | Pfizer, Inc. | Cannabinoid receptor ligands and uses thereof |
| US7390835B2 (en) * | 2003-10-30 | 2008-06-24 | Merck & Co., Inc. | Aralkyl amines as cannabinoid receptor modulators |
| CA2586011C (en) | 2004-07-12 | 2011-07-19 | Cadila Healthcare Limited | Tricyclic pyrazole derivatives as cannabinoid receptor modulators |
| US20060025448A1 (en) | 2004-07-22 | 2006-02-02 | Cadila Healthcare Limited | Hair growth stimulators |
| US7700597B2 (en) | 2004-12-03 | 2010-04-20 | Schering Corporation | Substituted piperazines as CB1 antagonists |
| WO2007084450A2 (en) * | 2006-01-18 | 2007-07-26 | Schering Corporation | Cannibinoid receptor modulators |
| CN101062919B (zh) * | 2006-04-26 | 2012-08-15 | 中国人民解放军军事医学科学院毒物药物研究所 | 4-甲基-1h-二芳基吡唑衍生物及其作为药物的用途 |
| WO2007121687A1 (en) * | 2006-04-26 | 2007-11-01 | Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China | 4-methyl-1h-diaryl pyrazole derivatives and their uses as medicament |
| US20070287734A1 (en) * | 2006-06-09 | 2007-12-13 | Auspex Pharmaceuticals, Inc. | Preparation and utility of substituted pyrazole compounds with cannabinoid receptor activity |
| RU2477634C2 (ru) * | 2006-06-16 | 2013-03-20 | Теракос, Инк. | Лечение психологических состояний с применением антагонистов m1-мускариновых рецепторов |
| CA2666587C (en) * | 2006-10-20 | 2015-12-22 | Solvay Pharmaceuticals B.V. | Micellar nanoparticles of chemical substances |
| WO2008130616A2 (en) * | 2007-04-19 | 2008-10-30 | Schering Corporation | Diaryl morpholines as cb1 modulators |
| CN101790521A (zh) * | 2007-06-28 | 2010-07-28 | 英特维特国际股份有限公司 | 作为cb1拮抗剂的取代哌嗪 |
| WO2009005646A2 (en) * | 2007-06-28 | 2009-01-08 | Schering Corporation | Substituted piperazines as cb1 antagonists |
| EP2095814A1 (de) * | 2008-02-26 | 2009-09-02 | Wolfgang J. Kox | Medikamentengestützter Nikotinentzug |
| WO2010018856A1 (ja) * | 2008-08-13 | 2010-02-18 | 持田製薬株式会社 | カンナビノイド受容体関連疾患の予防／改善または治療剤 |
| RU2533224C2 (ru) * | 2010-07-21 | 2014-11-20 | Мапикс Эс.Эй.Ар.Эл. | Способ лечения зависимости от психоактивных веществ, алкоголизма и табакокурения и лекарственное средство для лечения зависимости от психоактивных веществ, алкоголизма и табакокурения |
| WO2013068371A1 (en) | 2011-11-08 | 2013-05-16 | Intervet International B.V. | Soft chewable dosage form compositions of cannabinoid receptor type 1 (cb-1) antagonists |
| WO2014181357A1 (en) * | 2013-05-09 | 2014-11-13 | Council Of Scientific & Industrial Research | Novel pyrazole derivatives with silicon incorporation |
| US20200035118A1 (en) | 2018-07-27 | 2020-01-30 | Joseph Pandolfino | Methods and products to facilitate smokers switching to a tobacco heating product or e-cigarettes |
| US10897925B2 (en) | 2018-07-27 | 2021-01-26 | Joseph Pandolfino | Articles and formulations for smoking products and vaporizers |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5780051A (en) * | 1992-04-02 | 1998-07-14 | Dynagen, Inc. | Methods and articles of manufacture for nicotine cessation and monitoring nicotine use |
| FR2692575B1 (fr) * | 1992-06-23 | 1995-06-30 | Sanofi Elf | Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant. |
| FR2713225B1 (fr) * | 1993-12-02 | 1996-03-01 | Sanofi Sa | N-pipéridino-3-pyrazolecarboxamide substitué. |
| US5596106A (en) * | 1994-07-15 | 1997-01-21 | Eli Lilly And Company | Cannabinoid receptor antagonists |
| FR2758723B1 (fr) * | 1997-01-28 | 1999-04-23 | Sanofi Sa | Utilisation des antagonistes des recepteurs aux cannabinoides centraux pour la preparation de medicaments |
| FR2765107B1 (fr) * | 1997-06-26 | 2000-03-24 | Sanofi Sa | Utilisation d'un antagoniste specifique des recepteurs 5ht2 pour la preparation de medicaments utiles dans le traitement du syndrome d'apnee du sommeil |
| FR2789079B3 (fr) | 1999-02-01 | 2001-03-02 | Sanofi Synthelabo | Derive d'acide pyrazolecarboxylique, sa preparation, les compositions pharmaceutiques en contenant |
| FR2804604B1 (fr) * | 2000-02-09 | 2005-05-27 | Sanofi Synthelabo | Utilisation d'un antagoniste des recepteurs aux cannabinoides centraux pour la preparation de medicaments utiles pour faciliter l'arret de la consommation de tabac |
-
2000
- 2000-02-09 FR FR0001682A patent/FR2804604B1/fr not_active Expired - Fee Related
-
2001
- 2001-02-07 DK DK01907722T patent/DK1257275T3/da active
- 2001-02-07 ES ES01907722T patent/ES2240416T3/es not_active Expired - Lifetime
- 2001-02-07 AT AT01907722T patent/ATE292467T1/de not_active IP Right Cessation
- 2001-02-07 CN CNB018047130A patent/CN1250220C/zh not_active Expired - Fee Related
- 2001-02-07 SI SI200130365T patent/SI1257275T1/xx unknown
- 2001-02-07 DE DE60109903T patent/DE60109903T2/de not_active Expired - Fee Related
- 2001-02-07 US US10/203,077 patent/US6930122B2/en not_active Expired - Fee Related
- 2001-02-07 SK SK1129-2002A patent/SK284952B6/sk not_active IP Right Cessation
- 2001-02-07 CZ CZ20022698A patent/CZ296685B6/cs not_active IP Right Cessation
- 2001-02-07 CA CA002397262A patent/CA2397262C/en not_active Expired - Fee Related
- 2001-02-07 IL IL15071001A patent/IL150710A0/xx not_active IP Right Cessation
- 2001-02-07 NZ NZ519924A patent/NZ519924A/en unknown
- 2001-02-07 HU HU0300237A patent/HU225328B1/hu not_active IP Right Cessation
- 2001-02-07 PL PL358221A patent/PL201685B1/pl not_active IP Right Cessation
- 2001-02-07 RS YUP-590/02A patent/RS50404B/sr unknown
- 2001-02-07 EE EEP200200439A patent/EE04836B1/xx not_active IP Right Cessation
- 2001-02-07 PT PT01907722T patent/PT1257275E/pt unknown
- 2001-02-07 BG BG110386A patent/BG110386A/en unknown
- 2001-02-07 MX MXPA02007766A patent/MXPA02007766A/es active IP Right Grant
- 2001-02-07 EP EP01907722A patent/EP1257275B1/fr not_active Expired - Lifetime
- 2001-02-07 RU RU2002118309/15A patent/RU2257207C2/ru not_active IP Right Cessation
- 2001-02-07 WO PCT/FR2001/000356 patent/WO2001058450A2/fr not_active Ceased
- 2001-02-07 JP JP2001557560A patent/JP2003522145A/ja not_active Ceased
- 2001-02-07 BR BR0108126-8A patent/BR0108126A/pt not_active Application Discontinuation
- 2001-02-07 AU AU35620/01A patent/AU781827B2/en not_active Ceased
- 2001-02-09 AR ARP010100587A patent/AR028505A1/es unknown
- 2001-02-19 TW TW090102783A patent/TWI243677B/zh active
- 2001-07-02 UA UA2002075476A patent/UA72783C2/uk unknown
-
2002
- 2002-06-28 IS IS6450A patent/IS6450A/is unknown
- 2002-07-03 ZA ZA200205317A patent/ZA200205317B/en unknown
- 2002-07-23 BG BG106946A patent/BG65856B1/bg unknown
- 2002-08-08 NO NO20023765A patent/NO324521B1/no not_active IP Right Cessation
-
2005
- 2005-04-25 US US11/113,864 patent/US20050187253A1/en not_active Abandoned
-
2009
- 2009-09-18 JP JP2009217269A patent/JP2010018622A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2002118309A (ru) | Применение антагониста центральных каннабиноидных рецепторов для приготовления лекарств, предназначенных для облегчения прекращения курения | |
| BRPI0315315B8 (enExample) | ||
| HUP0001894A2 (hu) | N-Piperidino-3-pirazolkarboxamid-származékot, sóját vagy szolvátját tartalmazó orálisan adagolható gyógyszerkészítmény | |
| PE20081649A1 (es) | Combinaciones que comprenden agentes antimuscarinicos y agonistas beta-adrenergicos | |
| EP2210606A3 (en) | Compositions comprising immunomodulatory compounds for the treatment and management of myeloproliferative diseases | |
| HRP20030249A2 (en) | Association of the cb1 receptor antagonist and a sibutramin, pharmaceutical compositions containing same and use thereof for treating obesity | |
| JP2005512995A5 (enExample) | ||
| NO993520D0 (no) | Doseringsformer og fremgangsmåte for å bedre erektil dysfunksjon | |
| ATE308317T1 (de) | Zubereitungen mit einem anticholinergischen wirkstoff für die behandlung der chronischen obstruktiven lungenerkrankung | |
| LT2000064A (en) | Flash-melt oral dosage formulation | |
| TNSN04095A1 (en) | Pharmaceutical compositions comprising metformine and glibenclamide for the treatment of type-ii diabetes mellitus | |
| WO2005105088A3 (en) | Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of pulmonary hypertension | |
| GEP20094605B (en) | Pyrazole derivatives, compositions containing such compounds and methods of use thereof | |
| EP1386606A4 (en) | INJECTION STABLE, HIGH CONCENTRATION WITH A PYRAZOLON DERIVATIVE | |
| JP2019536812A5 (enExample) | ||
| WO2002016312A3 (de) | NEUE VERBINDUNGEN, DIE FAKTOR Xa-AKTIVITÄT INHIBIEREN | |
| ATE324112T1 (de) | Topische behandlung bei der mastalgie | |
| EP2072082A3 (en) | N-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-[1,3,4-oxadiazol-2-yl]phenyl)pyridine-3 sulfonamide as analgetic agent | |
| CA2473202A1 (en) | Pharmaceutical composition for regeneration of cirrhotic liver | |
| WO2005039497A3 (en) | Methods and compositions comprising thalidomide for treatment of fibromyalgia | |
| JP2003503453A5 (ja) | ガバペンチンおよびプレガバリンを含む相乗作用組成物 | |
| EA200800966A1 (ru) | Новая композиция, содержащая росиглитазон и другое противодиабетическое средство | |
| WO2004037228A8 (en) | Sustained release compositions containing alfuzosin | |
| EP1099441A3 (en) | Compositions containing apo B secretion/MTP inhibitors and anti-obesity agents and use thereof | |
| KR20070112266A (ko) | 칸나비노이드 수용체 길항제 화합물과 항정신병제의조합물을 함유하는 제약 조성물 |